Iodine -123 is a radioisotope used in single photon computed tomography (SPECT). It has a half-life of 13.2h It is mainly used and has been approved to confirm the diagnosis of Parkinson Disease by helping visualising the dopamine transporter levels in the brain and also for thyroid imaging.
123 gas target
Gas target loaded with enriched 124Xenon to provide 123I by natural decay. The gas target has a cryogenic recovery system for 124Xe (working in closed loop). The 123I is extracted by washing target with pure water.
Pinctada®
The target wash solution is purified by two ion exchange columns to provide a concentrated NaI solution for dispensing or labelling
Nirta® XETI gas target
Gas target loaded with enriched 124Xenon to provide 123I by natural decay. The gas target has a cryogenic recovery system for 124Xe (working in closed loop). The 123I is extracted by washing target with pure water.
Pinctada® 123I
The target wash solution is purified by two ion exchange columns to provide a concentrated NaI solution for dispensing or labelling
Nirta® solid target
Nirta® Solid target can be used for the irradiation of enriched 123Te via 123Te(p,n)123I nuclear reaction.
HighMOR®
The radioiodine separation is accomplished via thermo-distillation with the HighMOR® system at high temperature to release the iodine. Iodine is then trapped into a solution. This fully automated process is controlled by user-friendly software interface allowing separation in less than 4h.
Nirta® solid target
Nirta® Solid target can be used for the irradiation of enriched 123Te via 123Te(p,n)123I nuclear reaction.
Thermo distillation
The radioiodine separation is accomplished via thermo distillation at high temperature to release the iodine. Iodine is then trapped into a solution. This fully automated process is controlled by user-friendly software interface allowing separation in less than 4h.
P. Rajec, V. Csiba, M. Leporis, M. Štefečka, E. Losonczi Pataky, M. Reich, J. Ometákova
M.F.Catanoso, J.A.Osso Jr. Instituto de Pesquisas Energéticas e Nucleares IPEN/CNEN-SP Brazil
S. Chana, D. Cryera, A.H. Asada,b, R.I. Pricea,c a Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Perth, Western Australia b Imaging & Applied Physics, Curtin University, Western Australia c School of Physics, University of Western Australia, Western Australia
Faisal Alrumayan, F. Oberdorferb, Q. Akkam, J. Schneider, S. Alyanbawi and I. Al-Jammaz